Basic information Safety Supplier Related

Amyloid β-Protein (1-42) (mouse, rat)

Basic information Safety Supplier Related

Amyloid β-Protein (1-42) (mouse, rat) Basic information

Product Name:
Amyloid β-Protein (1-42) (mouse, rat)
Synonyms:
  • ASP-ALA-GLU-PHE-ARG-HIS-ASP-SER-GLY-TYR-GLU-VAL-HIS-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA
  • ASP-ALA-GLU-PHE-GLY-HIS-ASP-SER-GLY-PHE-GLU-VAL-ARG-HIS-GLN-LYS-LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA
  • BAP 1-42
  • BETA-AMYLOID, SODIUM SALT
  • Beta-Amyloid Peptide (1-42), mouse, rat
  • AMyloid b-Protein (1-42) (Mouse, rat)
  • PREDOMINANT AMYLOID B-PROTEIN FRAGMENT
  • 767: PN: US20090175821 SEQID: 961 claimed protein
CAS:
166090-74-0
MF:
C203H311N55O60S
MW:
0
Product Categories:
  • peptide
  • Neuroscience
Mol File:
Mol File
More
Less

Amyloid β-Protein (1-42) (mouse, rat) Chemical Properties

storage temp. 
−20°C
solubility 
Soluble in DMSO
form 
Solid
color 
White to off-white
Sequence
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala
More
Less

Safety Information

WGK Germany 
3

MSDS

More
Less

Amyloid β-Protein (1-42) (mouse, rat) Usage And Synthesis

Uses

Substrate Cleavage Assays (30-100 μg/ml)

Biological Activity

Amyloid beta-peptide (1-42) (rat) is a 42 amino acid polypeptide that is toxic to hippocampal slices and can be used in Alzheimer's disease research.

in vivo

β-Amyloid (1-42), (rat/mouse) can induce Alzheimer's disease[4].

Induction of Alzheimer's disease[4]
Background
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder mainly characterized by the abnormal accumulation of β-amyloid (Aβ) peptide. The oligomeric form of the Aβ peptide as being the critical initiator of neurotoxicity in the AD pathogenesis[4].
Specific Modeling Methods
Rat: Wistar ? male ? adult, weighing 240-260 g
Administration: 1 μg/μL ? Hippocampal injection ? single dose
Note
(1) β-Amyloid (1-42) needs to be processed into oligomers before use.
(2) β-Amyloid (1-42) was injected bilaterally into the hippocampus of rat brain in a volume of 1.0 μL over a period of 0.1 μL/min using 1 μL Hamilton syringe.
Modeling Indicators
Indicator changes: Decreased the gene expression level of α7-nAChR and increased the mRNA expression of NMDA receptor 2A, and -2B subunits.
Behavior: β-Amyloid (1-42) aggregates increased the retention time and altered the behavioral response in rats after 15 days of injection.
Correlated Product(s): β-Amyloid (1-42), (rat/mouse) TFA (HY-P1388A); β-Amyloid (1-40) (rat) (HY-P1387); β-Amyloid (1-40) TFA (HY-P0265A)
Opposite Product(s): /

target

Amyloid-beta

storage

Store at -20°C

Amyloid β-Protein (1-42) (mouse, rat)Supplier

Nanjing TGpeptide Biotechnology Co.,Ltd. Gold
Tel
18115476705
Email
sales@tgpeptide.com
Hangzhou Sinoda Pharmaceutical Technology Co. LTD Gold
Tel
0571-87213919 17306812703
Email
3007955328@qq.com
QYAOBIO (ChinaPeptides CO., Ltd.) Gold
Tel
021-50792271 18301728382
Email
cps041@chinapeptides.com
Shanghai YuanYe Biotechnology Co., Ltd. Gold
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com